Batoul Farran

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Ganji Purnachandra Nagaraju · 7 shared papers, 2019–2026 · strength 1.69
   • Paper Breaking the stromal barrier in pancreatic cancer: Advances and challenges. DOI 10.1016/j.bbcan.2023.189065↗
   • Paper Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventions. DOI 10.1038/s41392-026-02705-5↗
   • Paper Understanding the molecular mechanisms that regulate pancreatic cancer stem cell formation, stemness and chemoresistanc… DOI 10.1016/j.semcancer.2022.12.004↗
2. Bassel F. El‐Rayes · 3 shared papers, 2023–2026 · strength 0.79
   • Paper Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventions. DOI 10.1038/s41392-026-02705-5↗
   • Paper Understanding the molecular mechanisms that regulate pancreatic cancer stem cell formation, stemness and chemoresistanc… DOI 10.1016/j.semcancer.2022.12.004↗
   • Paper Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions. DOI 10.1016/j.cytogfr.2023.06.006↗
3. Chaithanya Ganji · 2 shared papers, 2022–2026 · strength 0.62
   • Paper Current clinical trials for epigenetic targets and therapeutic inhibitors for pancreatic cancer therapy. DOI 10.1016/j.drudis.2021.12.013↗
   • Paper Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventions. DOI 10.1038/s41392-026-02705-5↗
4. Seema Kumari · 2 shared papers, 2024–2026 · strength 0.55
   • Paper Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventions. DOI 10.1038/s41392-026-02705-5↗
   • Paper Small molecular inhibitors: Therapeutic strategies for pancreatic cancer. DOI 10.1016/j.drudis.2024.104053↗
5. Mohana Chakkera · 1 shared paper, 2024 · strength 0.31
   • Paper Breaking the stromal barrier in pancreatic cancer: Advances and challenges. DOI 10.1016/j.bbcan.2023.189065↗
6. Jeremy B. Foote · 1 shared paper, 2024 · strength 0.31
   • Paper Breaking the stromal barrier in pancreatic cancer: Advances and challenges. DOI 10.1016/j.bbcan.2023.189065↗
7. Mundla Srilatha · 1 shared paper, 2026 · strength 0.29
   • Paper Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventions. DOI 10.1038/s41392-026-02705-5↗
8. Tha Luong · 1 shared paper, 2023 · strength 0.26
   • Paper Understanding the molecular mechanisms that regulate pancreatic cancer stem cell formation, stemness and chemoresistanc… DOI 10.1016/j.semcancer.2022.12.004↗
9. Yuvasri Golivi · 1 shared paper, 2024 · strength 0.26
   • Paper Small molecular inhibitors: Therapeutic strategies for pancreatic cancer. DOI 10.1016/j.drudis.2024.104053↗
10. Sujith Sarvesh · 1 shared paper, 2023 · strength 0.24
    • Paper Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions. DOI 10.1016/j.cytogfr.2023.06.006↗
11. Dhana Sekhar Reddy Bandi · 1 shared paper, 2023 · strength 0.24
    • Paper Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions. DOI 10.1016/j.cytogfr.2023.06.006↗
12. Saikrishna Lakkakula · 1 shared paper, 2019 · strength 0.10
    • Paper Small molecule tyrosine kinase inhibitors and pancreatic cancer-Trials and troubles. DOI 10.1016/j.semcancer.2018.09.011↗
13. Nagendra Sastry Yarla · 1 shared paper, 2019 · strength 0.10
    • Paper Small molecule tyrosine kinase inhibitors and pancreatic cancer-Trials and troubles. DOI 10.1016/j.semcancer.2018.09.011↗
14. Lakkakula VKS Bhaskar · 1 shared paper, 2019 · strength 0.10
    • Paper Small molecule tyrosine kinase inhibitors and pancreatic cancer-Trials and troubles. DOI 10.1016/j.semcancer.2018.09.011↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.